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Summary when new and more tightly linked markers to the gene
are developed, when new information concerning family
The ﬁrst predictive testing for Huntington disease (HD) members is acquired, when the mutation underlying the
was based on analysis of linked polymorphic DNA disease is identiﬁed and direct mutation analysis is possi-
markers to estimate the likelihood of inheriting the mu- ble when misdiagnosis has occurred, or when persons
tation for HD. Limits to accuracy included recombina- at low risk unexpectedly manifest the signs and symp-
tion between the DNA markers and the mutation, pedi- toms of the disease. In addition, human error may cause
gree structure, and whether DNA samples were available an incorrect risk result. As a result, risk reversals are
from family members. With direct tests for the HD mu- possible in any predictive testing program that depends
tation, we have assessed the accuracy of results obtained only on linked DNA polymorphisms.
by linkage approaches when requested to do so by the Inaccuracy of the test and the absence of any effective
test individuals. For six such individuals, there was sig- treatment were two of the major concerns that were
niﬁcant disparity between the tests. Three went from a raised when predictive testing for HD ﬁrst became avail-
decreased risk to an increased risk, while in another able in 1986 (Bird 1985; Wexler 1985; Craufurd and
three the risk was decreased. Knowledge of the potential Harris 1986; Farrer 1986; Kessler 1987; Smurl and
reasons for these changes in results and impact of these Weaver 1987). With these concerns, a consensus devel-
risk reversals on both patients and the counseling team oped that tests should be offered only under the guide-
can assist in the development of strategies for the preven- lines of a protocol recommended by the World Federa-
tion and, where necessary, management of a risk reversal tion of Neurology and the International Huntington
in any predictive testing program. Association (1990). The identiﬁcation of the mutation
in the HD gene in 1993 (Huntington’s Disease Collabo-
rative Research Group 1993) enabled predictive testingIntroduction
to be done more accurately, using direct detection of the
CAG expansion, which should eliminate all but humanThe discovery of the ﬁrst DNA marker linked to Hun-
error as a cause for incorrect assignment of risk.tington disease (HD) (Gusella et al. 1983) led to the
A pilot project for predictive testing started in Van-development of a predictive test for HD. Subsequently,
couver, British Columbia, in 1986 (Bloch et al. 1989;additional markers were identiﬁed (Gilliam et al. 1987;
Fox et al. 1989) and expanded in 1988 to include 16Hayden et al. 1988;Wasmuth et al. 1988) that enhanced
genetics centers across Canada. Approximately 300 atthe informativeness of the test. The recombination rate,
risk individuals have received informative resultswhich could result in inaccurate assignment of risk, was
through linkage analysis, and ú1,000 individualsestimated as 1%–5%, depending on the proximity of
through direct assessment for the mutation. Of thosethe markers to the putative site of the HD mutation.
receiving results via linkage, six individuals have beenIncorrect assignment of risk is most likely identiﬁed
identiﬁed as receiving an incorrect risk result.
Here we report in detail on the risk reversals experi-
enced in our program, which highlight its impact notReceived May 1, 1997; accepted for publication July 14, 1997.
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land.
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We are unaware of reports of errors in genetic testing DNA available for assessment. He still wished to receive
his results and was later told that he had a 17% risk offor HD, even though they are likely to have occurred.
Forthright discussion of these issues provides an oppor- having inherited the gene for HD (ﬁg. 1A). The large
degree of uncertainty was due to the fact that both histunity to learn from these experiences, which will hope-
fully reduce their likelihood of recurrence and also high- father and his aunt had identical haplotypes. Therefore,
the only way to determine which of the two chromo-light approaches to deal with these difﬁcult situations.
somes carried the HD gene was by assessment of the
likelihood of homozygosity (based on the allele frequen-Methods
cies) for the polymorphisms comprising the different
Eligibility criteria and recruitment methods for the haplotypes.
Canadian Collaborative Study on Predictive Testing for Mr. G felt relieved and said that this was ‘‘great
HD have been described in detail elsewhere (Fox et al. news.’’ He talked about changing some things in his life,
1989). The protocol includes at least two preresults ses- such as reducing his life insurance coverage and possibly
sions, a results session, and at least three follow-up ses- having children. He stated that he felt ‘‘light’’ and ‘‘dif-
sions over a minimum period of 1 year after the patient ferent.’’ ‘‘I used to keep things bottled-up, especially
receives test results. my HD things.’’ His marriage was also improving for
Predictive testing was initially performed using DNA various reasons, only one of which was the predictive
analysis of genetic markers linked to HD. Between 6 and test result.
13 RFLPs were used to determine the informativeness of Two years later, Mr. G’s sister entered the predictive
the test. The risk estimate was then calculated using testing program and received a decreased risk estimate
the MLINK (version 3.5) subprogram of the LINKAGE of 2%. Our patient wanted to know why his own de-
program (Hayden et al. 1988), which takes into account creased risk was so much higher and requested retesting.
age at onset, age of the candidate, penetrance, and re- Since the assessment 2 years earlier, new highly poly-
combination frequency between the marker and the
gene. Once the gene was identiﬁed (Huntington Disease
Collaborative Research Group 1993), direct assessment
of the CAG repeat was performed by PCR ampliﬁcation
(Goldberg et al. 1993; Kremer et al. 1995). All data are
kept conﬁdentially in a master pedigree ﬁle in a locked
cabinet. When a particular family is being assessed, a
conﬁdential working pedigree ﬁle is created. Normal
individuals have CAG repeat sizes õ29, while individu-
als affected with HD have CAG repeat sizes ú35
(Kremer et al. 1994; Rubinsztein et al. 1996; Brinkman
et al. 1997). Repeat sizes of 29–35 CAG are called ‘‘in-
termediate alleles.’’ This designation has important clini-
cal implications, because although individuals with re-
peat sizes in this range are not at risk of developing HD
themselves, males are potentially at increased risk of
having offspring with HD (Goldberg et al. 1995; Chong
et al. 1997).
Case Histories
A Change from a Decreased to an Increased Risk
Result
Individual 1: new information on family members.—
At the time Mr. G requested predictive testing in 1989,
blood was available from only two affected family mem-
bers—his father and his aunt. (Every effort has been
made to protect the conﬁdentiality of patients by altering
Figure 1 Pedigree of individual 1, showing the alleles for threesome details that do not distort the clinical presenta-
different polymorphic markers (D4S95, D4S96, and D4S98) below
tion.) After some preliminary DNA analysis, he was in- the gender symbols. This represents a subset of all markers assessed,
formed that the accuracy of the risk estimate would be as it does for all ﬁgures that follow. The chromosome most likely
carrying the HD mutation is colored gray.reduced because of the particular family structure and
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morphic and informative DNA markers had been dis-
covered that increased the likelihood of informativeness
in this family. Furthermore, with DNA from a recently
ascertained third affected relative, clear identiﬁcation of
the affected chromosome in the family was now possible
(ﬁg. 1B). Preresults counseling focused on the fact that
there was a 17% chance that his risk estimate could be
altered. The wife admitted that the 17% risk had felt
the same as 50% to her. They were both anxious about
the upcoming results. When he received his revised risk,
he was informed that he had a 96% chance of having
inherited the gene for HD (ﬁg. 1B). Both he and his wife
were upset. His wife attempted to focus on the 4% of
hope that he had not inherited the gene, but he would
not let her, saying ‘‘This is bad news.’’ He never ex-
pressed anger with the counseling team or doubted these
results. In follow-up sessions, he did admit to being more
irritable and not sleeping as well. His wife felt he was
not adjusting well to the results, citing his moodiness
and depression and said they were having serious marital
problems.
Two years later, Mr. G indicated that his life was
on an ‘‘upswing.’’ His relationship with his wife had
improved, and they had decided against having children.
He had bought the company where he was working
and was attempting to plan his future ﬁnancial security.
When the direct test became available, he did not wish
to be tested again.
Individual 2: the issue of quality control.—Mr. A was
in his mid-30s when he ﬁrst entered the predictive testing
program in 1989. Many of the necessary blood samples
from affected relatives had already been banked, and a
working DNA ﬁle was begun. The counselor learned
that two of the individuals in the family had the same
name and notiﬁed the DNA Bank. The master pedigree
was changed accordingly. However, the pedigree in the
working ﬁle was not corrected. The DNA results re-
vealed that Mr. A had a 3% risk of having inherited the
gene for HD (ﬁg. 2A). He was elated, and he and his
ﬁance´e made plans to marry and to have a reversal of
his vasectomy. At the 2-mo follow-up appointment, Mr.
A reported that ‘‘every day feels like Christmas.’’
A few months later, another relative applied for pre-
dictive testing. It was then discovered that Mr. A’s result
had been assessed using the uncorrected pedigree. The
laboratory contacted the counselors immediately, and it
was indicated that this error invalidated the results that
he had been given. This was explained to Mr. A and
his ﬁance´e and it was emphasized that retesting could
produce an altered result. Initially the couple appeared
stunned. Mr. A stated that he understood ‘‘mistakes
happen.’’ His ﬁance´e however was visibly upset. They Figure 2 Pedigrees of individual 2 (A and B) and individual 3
both indicated that they wanted the new results as soon (C and D). Alleles for two of the polymorphic markers (D4S95 and
as possible. D4S96) analyzed are shown below the gender symbols. The chromo-
some most likely carrying the HD mutation is colored gray.Two weeks later, Mr. A contacted the genetics center
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and explained that he had decided to delay receiving the possible. After counseling, she returned to learn that her
new risk was 92% (ﬁg. 2D). She was devastated andnew results because he was in the middle of moving and
planning his wedding. Also, he had recently started a could not understand how such a dramatic shift could
have occurred.new job and wanted to establish his beneﬁts there in
case he was at increased risk. Seven months later, Mr. At the follow-up session a week later, Ms. N ex-
pressed anger and frustration. She wanted to ‘‘exerciseA contacted the genetics center to request the new re-
sults. The couple, who had been married in the interim, her rights,’’ and be retested. She wanted to gather new
blood samples from the entire family and start again.wanted the results for planning their family. Both Mr.
and Mrs. A were prepared for the possibility that he The counselors expressed the laboratory’s conﬁdence
in the new results but agreed to her request to redomight receive an increased risk result. At the results ses-
sion, Mr. A was informed that his risk was increased to the analysis. She felt she had been ‘‘slugged in the gut’’
and that 92% was as good as being told she had the95% (ﬁg. 2B). Mr. A expressed no anger, blame, or
regret about the test results, although he wistfully stated gene.
During the following few weeks, the patient graduallythat he was glad to have had the opportunity to know
what it felt like to live without the burden of risk. underwent a transition. She gave up the idea of collect-
ing new blood samples and being retested. However, sheDuring the following year, Mr. A did not complain
of any problems and appeared in remarkably good spir- still reported having crying outbursts at work and feeling
‘‘out of control.’’ She declined additional counseling ap-its. He and his wife were planning to build their own
home. He appeared to be determined to present an ‘‘all pointments with the genetics team but said that she
would call her psychologist or go to the emergency roomis well’’ view to the world. The counselor suspected that
Mr. A was not acknowledging his fears about the future if needed. She stated that the worst part for her was
having had the 2 mo of freedom from HD and thenbut noted that this coping mechanism seemed to be
working for him. having that taken away. She said she would not have
been so ‘‘shattered’’ if her ﬁrst result had been an in-Eighteen months after his revised results, Mr. A tele-
phoned the genetics center on several occasions re- creased risk. The predictive testing team lost contact
with Ms. N 6 mo after the new results, because sheporting periods of incapacitating anxiety. Twice an
emergency referral to an anxiety disorder clinic was moved to another part of the country to be closer to her
family. She did not respond to follow-up phone callsmade, but on neither occasion did he attend. He also
declined additional genetic counseling appointments but and letters.
did call to report that he was doing better. At the 2-year
A Change from an Increased to a Decreased Riskfollow-up, Mr. A was convinced that he was manifesting
symptoms of HD. His neurological examination, how- Individual 4: new information on family members.—
Mr. D was single and in his late 30s when he requestedever, was normal. He was also feeling tremendously
guilty about ruining his wife’s life and was unable to testing in 1987. His mother was the only living family
member affected with HD. She had ﬁve unaffected sib-accept her reassurances. Soon thereafter, the home that
Mr. A had built was burned accidentally. Immediately lings who were in their 50s or 60s. Since there was
only one affected individual in the family, Mr. D wasfollowing this traumatic event, Mr. A needed lengthy
psychiatric admissions during which he was diagnosed informed that his results would not be highly informa-
tive and that only a small shift in his prevailing riskas having HD.
Individual 3: the issue of quality control.—While the would be possible.
At his results session, he was informed that he had aDNA analysis for Mr. A’s ﬁrst test was being done, he
did not know that a cousin, Ms. N also entered the 80% risk of having inherited the gene for HD, on the
basis of the haplotype of his affected mother, her age atpredictive testing program. She had recently separated
from her husband. At her results session, she was given onset, and the haplotypes and current ages of unaffected
aunts and uncles (ﬁg. 3A). He stated that he had alwaysa 3% risk of having inherited the gene for HD, which
was based on the same pedigree as for individual 2 (ﬁg. expected that he would get HD and that knowing was
a relief. Two months later, some other family members2C). She appeared ecstatic with her results.
Twomonths later, the counseling center was informed attending follow-up sessions for their own predictive
testing results indicated that Mr. D’s sister was clearlyabout the laboratory error that could have inﬂuenced
her results. The genetic team contacted the patient im- showing signs of HD. However, she did not wish a medi-
cal examination. The counseling team had never seenmediately. She understood that a major change in the
risk estimate was possible. She did not appear angry the sister, and she resisted any efforts on the part of the
family to even talk about HD.with the unexpected turn of events and said that her life
had not changed much since she received her initial re- One year later, when the sister requested predictive
testing, she had concerns about her clinical status. Asult. Ms. N wished to receive the new results as soon as
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that her brother’s problems were due to drug abuse,
not HD. Soon after this new information, she requested
predictive testing. She indicated that she wished she had
known before her child was born, since she probably
would have had prenatal testing if she had an increased
risk.
Mrs. K was accompanied to the results session by her
mother. She was given a 90% risk of having inherited
the gene for HD (ﬁg. 4A). They were both upset. At
follow-up sessions, Mrs. K appeared to be more hopeful
for the future and was trying to get pregnant again.
Fifteen months after her results session, Mrs. K came in
excited because she was 8 wk pregnant and the gene for
HD had just been cloned. She wanted to have retesting
immediately. However, after some discussion it was evi-
dent that she was not going to make any decisions re-
garding this pregnancy on the basis of the results and
thus she decided to delay the direct testing until after
the baby was born. One year later, Mrs. K and her
mother returned to begin the process of retesting. The
counseling focused on all the possible outcomes, with
the most likely being that she had deﬁnitely inherited
the mutation associated with HD.
Direct testing was carried out, and Mrs. K was shown
to have inherited two normal alleles (ﬁg. 4B). In all
Figure 3 Pedigree of individual 4, showing the alleles for a sub-
set of three polymorphic markers (D4S10 HindIII, D4S10 Bgl and
D4S95) below the gender symbols. The chromosome most likely car-
rying the HD mutation is colored gray. Current age at the time of the
linkage analysis is printed in boldface, and age at onset is printed in
italics.
neurological examination conﬁrmed the diagnosis of
HD. Shortly thereafter, Mr. D attended his 2-year fol-
low-up session and was keen to know whether his risk
had been altered because of the availability of DNA
from his affected sister. Repeat genetic analysis indicated
that he had a 2% risk of having inherited the gene for
HD (ﬁg. 3B). He was delighted to receive this informa-
tion. He talked of reversing his vasectomy and having
children, of quitting his habit of frequent marijuana use,
and of getting his debt load under control. At the same
time, he expressed concern for his sister and some guilt
feelings that he was the survivor of the two. Three years
after the risk reversal, he was in a committed common-
law relationship and had undergone a reversal of his
vasectomy. He expressed no interest in having direct
gene testing.
Individual 5: possible recombination event.—Mrs. K
was in her mid 20s, had recently married and had a
baby, and was contemplating having more children
Figure 4 Pedigree of individual 5. Alleles for four of the poly-
when her mother told her that she was at risk for HD. morphic markers (D4S95, D4S96, D4S111, and D4S227) analyzed
For some years she had been told incorrectly that her are shown below the gender symbols. The chromosome most likely
carrying the HD mutation is colored gray.father, who had HD, was not her biological father and
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likelihood, a recombination event had occurred between
the markers and the HD gene, now leading to a de-
creased risk result. Another explanation for this result
was that the affected father was homozygous for all
markers tested; however, this possibility was very un-
likely. The reaction to the new results was one of disbe-
lief and shock. Slowly, Mrs. K began to realize the im-
pact this was going to have on her family and that her
children were no longer at risk. She wanted to have a
copy of the results, and at the end of the session re-
quested to go to the lab and see the actual raw data.
The months following the results were a happy time
for this family. Mrs. K stated that the issue of HD had
faded for her and that she rarely thought about it. She
was considering changing her job and having another
child, options that she would not have considered if she
had inherited the mutation for HD.
Individual 6: new scientiﬁc information.—Mrs. D re-
quested predictive testing because her sister was diag-
nosed with HD. There was no other known family his-
tory of HD. Mrs. D’s father was 82 years of age and in
good health, while her mother had died at the age of 44
years from Hodgkin disease. Testing to rule out alterna-
tive diagnoses and nonpaternity was undertaken on her Figure 5 Pedigree of individual 6, showing the alleles for a sub-
set of two polymorphic markers (D4S10 and D4S95) below the gendersister.
symbols (A). The chromosome most likely carrying the HD mutationMrs. D was anxious to proceed with predictive test-
is colored gray. Current age at the time of the linkage analysis ising, since she felt that her life, and that of her children’s,
printed in boldface, age at onset in italics. The CAG repeat size in the
were on hold until they could have some modiﬁcation HD gene is shown in panel B, and intermediate allele size is abbrevi-
of her risk. Thus, after lengthy counseling, which ated as IA.
stressed the limits of the test results and the fact that
haplotype analysis could only indicate whether Mrs. D
shared haplotypes with her affected sister, we proceeded spring, and we were not able to completely eliminate
with the DNA analysis. Mrs. D was informed that she the risk for HD to them.
did share a maternal haplotype with her sister and that
she therefore had a 85% risk of having inherited the Discussion
gene for HD (ﬁg. 5A). She was very disappointed, not
so much for herself as for the serious implications for More than 300 persons have received informative
DNA results through linkage analysis in the predictiveher children.
At each follow-up over the next 5 years, Mrs. D testing program for HD in Canada. Here we describe
six individuals who had disparity between results of di-continued to be healthy. When the gene for HD was
identiﬁed, she requested retesting. At her second re- rect and linkage testing. Even though these events are
rare, if a disparity is detected, a plan has to be developedsults session, she was told that her risk of developing
HD was now very low (ﬁg. 5B). In fact, she had inher- as to how to provide this information. Risk reversals
are likely to occur in any predictive testing programited an intermediate allele with a CAG repeat size of
35. Her father also had a CAG size of 35, which had using linkage analysis, e.g., multiple endocrine neoplasia
type 1 (Sandelin et al. 1994), breast cancer (Radfordexpanded on transmission to her sister. Mrs. D had
in fact inherited exactly the same chromosome as her and Zehnbauer 1996), and spinocerebellar ataxia type
3 (Verschuuren-Bemelmans et al. 1995), and thereforesister but with different CAG lengths. Thus, while she
was no longer at risk of developing HD herself, this considerations for how to deal with this have relevance
for these genetic disorders.intermediate allele had the small possibility of ex-
panding into the HD range, in particular on transmis- A risk reversal may have signiﬁcant impact on individ-
uals receiving this modiﬁed risk. The most demandingsion through the male germ line. She acknowledged
that it was indeed good news for her that we had never risk reversals for both the patient and the counseling
team were those that were due to human error (individu-seen anyone with 35 CAG repeats or less develop HD.
However, her primary focus had always been her off- als 2 and 3). These two individuals both went from a
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decreased risk to an increased risk and had long-term is provided. In our program, we discussed these issues
with each candidate on a case-by-case basis and gavedifﬁculties. For individual 2, however, difﬁculties ap-
peared to coincide with the onset of the disease. Follow- patients the option to pursue testing or not. This may,
however, be a place for a more directive approach, pri-ing that, associated with the experience with individuals
2 and 3, a more rigorous laboratory protocol of sample marily because it might be difﬁcult for patients to under-
stand fully a partial modulation of risk. On the basis ofveriﬁcation and clinical/laboratory communication was
instituted. these experiences, despite urging by predictive testing
participants, a more conservative approach that post-The case history for individual 2 illustrates the impor-
tance of offering a choice to the candidate as to whether pones testing until more clinical or scientiﬁc information
becomes available might be warranted.to proceed or not with the new risk estimate. In this
situation, even though the counselors thought that the An important ethical and legal question can be raised
whether the geneticist has a duty to recontact their pa-client would want the most accurate information, he
chose not to receive it at that time. This has inﬂuenced tients when new information for a genetic test becomes
available. This issue has been discussed by Pelias (1991)our approach in dealing with change of risk detected
with different technologies. We ﬁrst inform the test can- who suggested that the physician ‘‘has a continuing obli-
gation to re-contact former clients when he receives newdidate that new information has become available and,
second, explore with them whether they wish to have information that could be material in their lives’’ (p.
352). This would suggest that a patient who has partici-this new information.
The unpredictability of individual responses is illus- pated in genetic testing must be informed of the avail-
ability of a direct test. As to our knowledge, differenttrated by individual 1, who was not only accepting of
his increased risk result but appeared to make more approaches have been used to deal with this particular
issue in predictive testing for HD. Some test centers in-positive adjustments in his life in the position of being
at increased risk than when he believed he was at de- formed their participants about the direct test through
the newsletter of the lay organization for HD, whilecreased risk. Similar narratives have been reported else-
where, illustrating the unexpected responses that some other centers wrote a personal letter to the test candi-
dates who had linkage testing. However, clearly oneindividuals have with adjusting to their new risk status
(Bloch et al. 1992; Huggins et al. 1992). could argue that the patient also has a responsibility to
keep themselves informed about new discoveries thatIt is noteworthy that four of the six risk reversals
occurred for individuals whose initial risk estimates might have implications on their lives (Pelias 1991). The
physician-patient relationship imposes duties on bothranged from 10%–20%, or 80%–90% likelihood of
having inherited the mutation for HD. By deﬁnition, it patient and counselor, including recommendations for
further contact and, where necessary, follow-up visitswas more likely that these persons would have a higher
risk of an inaccurate result. This highlights the impor- to ascertain new information. At the present time, we
would favor an approach that takes into account appro-tance of patients understanding the limitations of link-
age analysis, particularly for a partially informative test priate conﬁdentiality while providing participants with
new information in general about the latest scientiﬁcresult. It is also important to inform individuals in any
predictive testing program that the interpretation of information and the availability of counseling.
As identiﬁcation of genetic risk moves from linkagetheir results are based on the current knowledge and
that this might change in the future as new scientiﬁc analysis to direct mutation testing for this and other
diseases, further risk reversals will occur. Knowledge ofﬁndings become available. This is shown in the case of
individual 6, who received an increased risk but, after the impact of these reversals is important to developing
approaches for delivery of this new information to thethe HD gene was identiﬁed, was found to have a CAG
repeat length in the intermediate range, which reduced patient.
her risk even though she had inherited the same chromo-
some 4 as her affected sister.
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